Gi Hong CHOI Korea (Republic of)

CURRICULUM VITAE PERSONAL DATA Name in Full : Gi Hong Choi, M.D. PhD. Sex : Male Date of Birth : June 25, 1972 - Korea Citizenship : Korean Mailing Address : Department of Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul 120-752, Korea Phone : +82-2-2228-2099 Fax : +82-2-313-8289 E-mail Address : Choigh@yuhs.ac Present Academic & Hospital Appointments Professor Division of Hepato-Biliary-Pancreatic Surgery. Department of Surgery, Severance Hospital. Yonsei University, College of Medicine, Seoul, Korea EDUCATION 1992. 3. 1 - 1998. 2. 28 Yonsei University College of Medicine, Seoul, Korea 2006. 3. 1 - 2008. 2. 28 Master Degree, Graduate School, Yonsei University 2009. 3. 1 – 2013. 2. 28 Doctoral Degree, Graduate School, Yonsei University WORK EXPERIENCE 2006. 3. 1-2007. 2. 28 Clinical and research fellowship, Department of Surgery, Severance Hospital, Yonsei University College of Medicine 2008. 3.1 -2009. 2. 28 Full-time Faculty Instructor Department of Surgery, Severance Hospital, Yonsei University College of Medicine 20093. 1 – 2013. 2. 28 Assistant Professor Department of Surgery, Severance Hospital, Yonsei University College of Medicine 2014. 9. 1-2015. 8. 30 Visiting associate professor, University of California, SanFrancisco, USA. 2014. 3. 1- 2019. 2. 28 Associate Professor Department of Surgery, Severance Hospital, Yonsei University College of Medicine 2019. 3. 1- Professor Department of Surgery, Severance Hospital, Yonsei University College of Medicine LICENSE AND CERTIFICATIONS Licensed to Practice Medicine in Korea, 1998. #63958 Korean Board of General Surgery, 2003. #5176 RESEARCH INTERESTS Minimally invasive liver resection (laparoscopic and robotic surgery) Surgical treatment for primary and metastatic liver cancer Liver transplantation for hepatocellular carcinoma MEMBERSHIPS Member of The Interanational Hepato-Pancreatico-Biliary Association Member of The Clinical Robotic Surgery Association Member of The Korean Association of Surgical Society Member of The Korean Association of Hepato-Biliary-Pancreatic Surgery Member of The Korean Association of the Study of Liver Member of The Korean Liver Cancer Study Group Member of The Korean Society for Transplantation EXPERIENCE OF CLINICAL TRIALS A Phase III randomized, double-blind, placebo-controlled study of sorafenib as adjuvant treatment for hepatocellular carcinoma after surgical resection or local ablation (BAY 43-9006/Study No. 12414) A prospective, randomized, double-blind, placebo controlled, parallel-group, international multicenter Phase III trial of PI-88 in the adjuvant treatment of subjects with hepatitis virus related Hepatocellular Carcinoma after surgical resection (PATRON) - 4-2011-0795 PUBLICATION BOOK Kim KH and Choi GH. Robotic liver resection In: Di Carlo, ed. Open, laparoscopic and robotic hepatic transection: Tools and Methods. Springer 2012. Choi GH and Choi JS. Robotic right hepatecotmy. In: Horacio J. Asbun and David A. Geller. ACS Multimedia Atlas of Surgery: Liver Surgery Volume. Cine-Med 2014. ORIGINAL ARTICLES 1. Choi M, Han DH, Kim KS, Choi JS, Kim BK, Kim SU, Seong J, Kim DY, Choi GH (co-corresponding author). Is liver resection still required for patients who have predictive factors for complete pathologic necrosis after downstaging treatments of locally advanced hepatocellular carcinoma? Eur J Surg Oncol. 2024. (Online ahead of print) 2. Cheah YL, Yang HY, Simon CJ, Akoad ME, Connor AA, Daskalaki D, Han DH, Brombosz EW, Kim JK, Tellier MA, Ghobrial RM, Gaber AO, Choi GH. The learning curve for robotic living donor right hepatectomy: Analysis of outcomes in two specialized centers. Liver Transp 2024 (Online ahead of print) 3. Kim NR, Han DH, Joo DJ, Lee JG, Kim DG, Kim MS, Choi JS, Choi GH (corresponding author). Propensity Score-matched Donor and Recipient Outcomes: Robotic Versus Laparoscopic Donor Right Hepatectomy. Transplantation 2024 (Online ahead of print) 4. Yoo JJ, Park DA, Ryoo S, Park J, Choi GH (co-corresponding author). Comparing laparoscopic and open resection in elderly hepatocellular carcinoma: a systematic review and meta-analysis. J Gastrointest Oncol 2024;15:1153-1164 5. Kim NR, Bae H, Hwang HS, Han DH, Kim KS, Choi JS, Park MS, Choi GH (co-corresponding author). Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver Resection. Liver Cancer. 2023;13:181-192. 6. Kim NR, Rho SY, Navarro J, An C, Han DH, Choi JS, Kim MJ, Choi GH (corresponding author). Additional nodules detected using EOB-MRI in patients with resectable single hepatocellular carcinoma: an implication for active treatment strategy. J Liver Cancer. 2024;24:92-101. 7. Yim SH, Min EK, Choi MC, Kim DG, Han DH, Joo DJ, Choi JS, Kim MS, Choi GH (co-corresponding author), Lee JG. Unusual grafts for living-donor liver transplantation. Eur J Med Res 2023 Oct 24;28(1):454 8. Kim NR, Alhothaifi ED, Han DH, Choi JS, Choi GH (corresponding author). Prognostic impact of R1 resection margin in synchronous and simultaneous colorectal liver metastasis resection: a retrospective cohort study. World J Surg Oncol. 2023 Jun 7;21(1):169 9. Hong SS, Han DH, Kim KS, Choi JS, Choi GH (corresponding author). Left-sided Hepatectomy Leads to Less Postoperative Liver Failure and Comparable Overall Survival to Right-sided Hepatectomy in Type II or IV Perihilar Cholangiocarcinoma. Ann Surg Oncol 2022. 10. Choi M, Han DH, Choi JS, Choi GH (corresponding author). Can the presence of KRAS mutations guide the type of liver resection during simultaneous resection of colorectal liver metastasis? Ann Hepatobiliary Pancreat Surg. 2022 May 31;26(2):125-132. 11. Hwang HS, Yoo JE, Han DH, Choi JS, Lee JG, Joo DJ, Kim MS, Kim SI, Choi GH (co-corresponding author), Park YN. Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation. Gut Liver 2022 May 15;16(3):443-455. 12. Tagaytay TG, Han DH, Chong JU, Hwang HS, Choi GH (corresponding author), Kim KS. Laparoscopic Minor Liver Resections for Hepatocellular Carcinoma in the Posterosuperior Segments Using the Rubber Band Technique. World J Surg. 2022 May;46(5):1151-1160 13. Rho SY, Lee JG, Joo DJ, Kim MS, Kim SI, Han DH, Choi JS, Choi GH (corresponding author). Outcomes of Robotic Living Donor Right Hepatectomy From 52 Consecutive Cases: Comparison With Open and Laparoscopy-assisted Donor Hepatectomy. Ann Surg 2022 Feb 1;275(2):e433-e442 14. Yang HY, Rho SY, Han DH, Choi JS, Choi GH (corresponding author). Robotic major liver resections: Surgical outcomes compared with open major liver resections. Ann Hepatobiliary Pancreat Surg. 2021 Feb 28;25(1):8-17. 15. Jung YB, Yoo JE, Han DH, Kim KS, Choi JS, Kim DY, Park YN, Choi GH (co-corresponding author). Clinical and survival outcomes after hepatectomy in patients with non-alcoholic fatty liver and hepatitis B-related hepatocellular carcinoma. HPB (Oxford). 2021 Jul;23(7):1113-1122. 16. Chiow AKH, Rho SY, Wee IJY, Lee LS, Choi GH (co-corresponding author). Robotic ICG guided anatomical liver resection in a multi-centre cohort: an evolution from "positive staining" into "negative staining" method. HPB (Oxford). 2021 Mar;23(3):475-482. 17. Choi SH, Han DH, Lee JH, Choi Y, Lee JH, Choi GH. Safety and feasibility of robotic major hepatectomy for novice surgeons in robotic liver surgery: A prospective multicenter pilot study. Surg Oncol. 2020 Dec;35:39-46. 18. Navarro JG, Kang I, Rho SY, Choi GH (corresponding author), Han DH, Kim KS, Choi JS. Major Laparoscopic Versus Open Resection for Hepatocellular Carcinoma: A Propensity Score-Matched Analysis Based on Surgeon’s Learning Curve. Ann Surg Oncol 2021 Jan;28(1):447-458. 19. Kang I, Jang M, Lee JG, Han DH, Joo DJ, Kim KS, Kim MS, Choi JS, Kim SI, Park YN, Choi GH (co-corresponding author). Subclassification of Microscopic Vascular Invasion in Hepatocellular Carcinoma. Ann Surg 2021 Dec;274(6):e1170-e1178. 20. Navarro JG, Lee JH, Kang I, Rho SY, Choi GH (corresponding author), Han DH, Kim KS, Choi JS. Prognostic significance of and risk prediction for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection? HPB (Oxford). 2020 Oct;22(10):1411-1419. 21. Navarro JG, Kang I, Rho SY, Choi GH (corresponding author), Han DH, Kim KS, Choi JS. Stepwise development of laparoscopic liver resection skill using rubber traction technique. HPB (Oxford). 2020 Aug;22(8):1174-1184. 22. Navarro JG, Yang SJ, Kang I, Choi GH (corresponding author), Han DH, Kim KS, Choi JS. What are the most important predictive factors for clinically relevant posthepatectomy liver failure after right hepatectomy for hepatocellular carcinoma? Ann Surg Treat Res 2020 Feb;98(2):62-71. 23. Lee JY, Rho SY, Han DH, Choi JS, Choi GH (corresponding author). Unplanned conversion during minimally invasive liver resection for hepatocellular carcinoma: risk factors and surgical outcomes. Ann Surg Treat Res. 2020 Jan;98(1):23-30. 24. Kim HS, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Park YN, Han DH, Kim KS, Choi JS, Choi GH (co-corresponding author), Kim HS. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection. Clin Mol Hepatol. 2020 Jan;26(1):33-44. 25. Navarro J, Rho SY, Kang I, Choi GH (co-corresponding author), Min BS. Robotic simultaneous resection for colorectal liver metastasis: feasibility for all types of liver resection. Langenbecks Arch Surg. 2019 Nov;404(7):895-908. 26. Navarro JG, Choi GH (corresponding author)., Kim MS, Jung YB, Lee JG. Right anterior section graft for living-donor liver transplantation: A case report. Medicine (Baltimore). 2019 May;98(19):e15212 27. Kawasaki Y, Yang SJ, Choi GH (corresponding author), Han DH, Lee JH, Iino S, Sakoda M, Ueno S, Natsugoe S, Choi JS. New scoring system for resectable hepatocellular carcinoma with a maximum tumor size of ≤5 cm based on preoperative tumor factors. HPB (Oxford). 2019 Oct;21(10):1393-1399 28. Melstrom LG, Eng OS, Raoof M, Singh G, Fong Y, Latorre K, Choi GH, Salem R, Bentrem DJ, Lewandowski R, Makris E, Poultsides G, Dhar VK, Chadalavada S, Shah SA, Johnson AC, Sekhar A, Kies D, Maithel SK, Rocha F, Alseidi A, Hagendoorn J, Borel Rinkes IHM, Fisher AV, Ronnekleiv-Kelly S, Weber SM, Winslow ER, Abbott DE. Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience. HPB (Oxford). 2019 Nov;21(11):1520-1526 29. Liu R, Wakabayashi G, Kim HJ, Choi GH, Yiengpruksawan A, Fong Y, He J, Boggi U, Troisi RI, Efanov M, Azoulay D, Panaro F, Pessaux P, Wang XY, Zhu JY, Zhang SG, Sun CD, Wu Z, Tao KS, Yang KH, Fan J, Chen XP. International consensus statement on robotic hepatectomy surgery in 2018. World J Gastroenterol. 2019 Mar 28;25(12):1432-1444. 30. Jeon MY, Kim HS, Lim TS, Han DH, Kim BK, Park JY, Kim DY, Ahn SH, Choi GH, Choi JS, Han KH, Kim SU. Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection. PLoS One. 2019 Apr 4;14(4) 31. Kim S, Shin J, Kim DY, Choi GH, Kim MJ, Choi JY. Radiomics on gadoxetic acid-enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma. Clin Cancer Res. 2019 Feb 26 32. Nota CL, Woo Y, Raoof M, Boerner T, Molenaar IQ, Choi GH, Kingham TP, Latorre K, Borel Rinkes IHM, Hagendoorn J, Fong Y. Robotic Versus Open Minor Liver Resections of the Posterosuperior Segments: A Multinational, Propensity Score-Matched Study. Ann Surg Oncol. 2019 Feb;26(2):583-590 33. Kim SH, Han DH, Choi GH, Choi JS, Kim KS. Oncologic Impact of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a Propensity Score-Matched Study. J Gastrointest Surg. 2019 Mar;23(3):538-544 34. Chong JU, Choi GH, Han DH, Kim KS, Seong J, Han KH, Choi JS. Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Ann Surg Oncol. 2018 Oct;25(11):3308-3315 35. Kim YJ, Yoo JE, Jeon Y, Chong JU, Choi GH, Song DG, Jung SH, Oh BK, Park YN. Suppression of PROX1-mediated TERT expression in hepatitis B viral hepatocellular carcinoma. Int J Cancer. 2018 Dec 15;143(12):3155-3168. 36. Wong DJ, Wong MJ, Choi GH, Wu YM, Lai PB, Goh BKP. Systematic review and meta-analysis of robotic versus open hepatectomy. ANZ J Surg. 2019 Mar;89(3):165-170 37. Choi GH, Chong JU, Han DH, Choi JS, Lee WJ. Robotic hepatectomy: the Korean experience and perspectiveHepatobiliary Surg Nutr. 2017 Aug;6(4):230-238 38. Lee HW, Choi GH (primary co-author), Kim DY, Park YN, Kim KS, Choi JS, Ahn SH, Han KH. Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection. Oncology. 2017;93:224-232 39. Kim JK, Park JS, Han DH, Choi GH (corresponding author), Kim KS, Choi JS, Yoon DS. Robotic versus laparoscopic left lateral sectionectomy of liver. Surg Endosc 2016;30:4756-64 40. Choi SH, Choi GH (corresponding author), Han DH, Kwon SW, Choi JS. Laparoscopic right hepatectomy: Toward Protocolization and Simplication. Ann Surg Oncol. 2017;24:554-5. 41. Lee JH, Han DH, Jang DS, Choi GH (corresponding author), Choi JS. Robotic extrahepatic Glissonean pedicle approach for anatomic liver resection in the right liver: techniques and perioperative outcomes. Surg Endosc 2016;30:3882-8 42. Han DH, Choi SH, Park EJ, Kang DR, Choi GH (corresponding author), Choi JS. Surgical outcomes after laparoscopic or robotic liver resection in hepatocellular carcinoma: a propensity-score matched analysis with conventional open liver resection. Int J Med Robot 2016;30:735-42 43. Choi GH, Kim GI, Yoo JE, Na DC, Han DH, Roh YH, Park YN, Choi JS.Kim DH, Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma. Ann Surg Oncol 2015;22 Suppl 3:1444-52. 44. Lim JH, Choi GH, Choi SH, Lee HS, Kim KS, Choi JS. Ventral segment-preserving right hepatectomy in patients with hepatocellular carcinoma. World J Surg. 2015;39:1034-43 45. Choi SH, Choi GH (corresponding author), Han DH, Choi JS. Laparoscopic liver resection using a rubber band retraction technique: usefulness and perioperative outcome in 100 consecutive cases. Surg Endosc 2015;29:387-97. 46. Han DH, Choi GH, Park JY, Ahn SH, Kim KS, Choi JS, Han KH. Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years. World J Surg Oncol 2014;12:192 47. Lee HS, Choi GH, Choi JS, Kim KS, Han KH, Seong J, Ahn SH, Kim do Y, Park JY, Kim SU, Kim BK. Surgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapy. Ann Surg Oncol. 2014;21:3646-53. 48. Lee HS, Choi GH, Joo DJ, Kim MS, Choi JS, Kim SI. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation. Ann Surg Oncol. 2014;21:2717-24. 49. Lee HS, Choi GH, Kang DR, Han KH, Ahn SH, Kim do Y, Park JY, Kim SU, Choi JS. Impact of spontaneous hepatocellular carcinoma rupture on recurrence pattern and long-term surgical outcomes after partial hepatectomy. World J Surg. 2014;38:2070-8. 50. Woo Y, Choi GH, Min BS, Hyung WJ. Novel application of simultaneous multi-image display during complex robotic abdominal procedures. BMC Surg. 2014;14:13 51. Kim SH, Choi GH, Kang CM, Kim KS, Choi JS, Lee WJ. Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer. World J Surg 2013 52. Yoo EJ, Shin HS, Kim SU, Joo DJ, Park JY, Choi CH, Kim do Y, Ahn SH, Seong K, Koh MJ, Han KH, Chon CY. Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma. Onco Targets Ther. 2013;6:755-9. 53. Han DH, Choi GH, Kim KS, Choi JS, Park YN, Kim SU, Park JY, Ahn SH, Han KH. Prognostic significance of the worst grade in hepatocellular carcinoma with heterogenous histologic grades of differentiation. J Gastroenterol Hepatol. 2013;28:1384-90. 54. Choi SH, Choi GH, Kim SU, Park JY, Joo DJ, Ju MK, Kim MS, Choi JS, Han KH, Kim SI. Role of surgical resection for multiple hepatocellular carcinoma. World J Gastroenterol. 2013;19:366-74. 55. Choi SH, Choi GH, Han DH, Choi JS, Lee WJ. Clinical feasibility of inferior right hepatic vein-preserving trisegmentectomy 5, 7, and 8 (with video). J Gastrointest Surg. 2013;17:1153-60. 56. Lim JH, Choi GH (corresponding author), Choi SH, Kim KS, Choi JS, Lee WJ. Liver resection for Bismuth type I and type II hilar cholangiocarcinoma. World J Surg 2013;37:829-37. 57. Oh TG, Chung MJ, Bang S. Park SW, Chung JB, Song SY, Choi GH, Kim KS, Lee WJ, Park JY. Comparison of the sixth and seventh editions of the AJCC TNM classification for gallbladder cancer. J Gastrointest Surg 2013;17:925-30. 58. Hwang DW, Han HS, Yoon YS, Cho JY, Kwon Y, Kim JH, Park JS, Yoon DS, Choi IS, Ahn KS, Kim YH, Jang KJ, Kim YH, Roh YH, Chu CW, Kim HC, Kang CM, Choi GH, Kim KS, Lee WJ, Yun SS, Kim HJ, Min SK, Lee HK, Song IS, Chun KS, Cho EH, Han SS, Park SJ. Laparoscopic major liver resection in Korea: a multicenter study. J Hepatobiliary Pancreat Sci 2013;20:125-30. 59. Kim SH, Kim DY, Lim JH, Kim SU, Choi GH, Ahn SH, Choi JS, Kim KS. Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism. ANZ J Surg. 2012; 60. An C, Choi GH, Lee HS, Kim MJ. Assessment of preoperative magnetic resonance imaging staging in patients with hepatocellular carcinoma undergoing resection compared with the seventh American Joint Committee on Cancer System. Invest. Radiol. 2012;47:634-41. 61. Lee CR, Lim JH, Kim SH, Ahn SH, Park YN, Choi GH, Choi JS, Kim KS. A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients. J Gastrointest Surg 2012;16:1736-43. 62. Cho MS, Kim SH, Park SW, Lim JH, Choi GH, Park JS, Chung JB, Kim KS. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single institute experience. J Gastrointest Surg. 2012;16:1672-9. 63. Jung KS, Kim SU, Choi GH, Park YJ, Park YN, Kim DY, Ahn SH, Chon CY, Kim KS, Choi EH, Choi JS, Han KK. Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan). Ann Surg Oncol. 2012;19:4278-86. 64. Shin SJ, Ahn JB, Choi JS, Choi GH, Lee KY, Baik SH, Min BS, Hur H, Roh JK, Kim NK. Implications of clinical risk score to predict outcomes of liver-confined metastasis of colorectal cancer. Surg Oncol. 2012;21:125-30. 65. Joo DJ, Ju MK, Huh KH, Kim MS, Choi GH, Choi JS, Jeon KO, Kim SI. Does lymphocyte cross-matching predict acute rejection and graft survival in liver transplantion? Transplant Proc. 2012;44:418-20. 66. Ju MK, Choi GH, Park JS, Yoon DS, Choi JS, Kim MS, Kim SI. Differences of regeneration potential between healthy and diseased liver. Transplant Proc. 2012;44:338-40. 67. Chon YE, Choi GH (primary coauthor), Lee MH, Kim SU, Kim DY, Ahn SH, Kim KS, Choi JS, Han KH, Chon CY, Park JY. Combined measurement of preoperative a-fetroprotein and des-r-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma. Int J Cancer 2012;131:2332-41. 68. Choi GH, Choi SH, Kim SH, Hwang HK, Kang CM, Choi JS, Lee WJ. Robotic liver resection: technique and results of 30 consecutive procedures. Surg Endo 2012;26:2247-58. 69. Kim BK, Kim SU, Choi GH, Han WK, Park MS, Kim EH, Park JY, Kim do Y, Choi JS, Yang SC, Choi EH, Song K, Ahn SH, Han KH, Chon CY. "Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population J Gastroenterol Hepatol. 2012 ;27:781-8 70. Jeong HT, Kim MJ, Kim YE, Park YN, Choi GH, Choi JS. MRI features of hepatocellular carcinoma expressing progenitor cell markers. Liver Int. 2012 ;32:430-40 71. Jeong HT, Kim MJ, Park MS, Choi JY, Choi JS, Kim KS, Choi GH, Shin SJ. Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging. J Magn Reson Imaging. 2012;35:635-43 72. Kim SH, Han YD, Lee JG, Kim do Y, Choi SB, Choi GH, Choi JS, Kim KS. MELD-based indices as predictors of mortality in chronic liver disease patients who undergo emergency surgery with general anesthesia. J Gastrointest Surg. 2011;15:2029-35. 73. Chun YH, Kim SU, Park JY, Kim do Y, Han KH, Chon CY, Kim BK, Choi GH, Kim KS, Choi JS, Ahn SH. Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. Eur J Cancer. 2011;47:2568-75. 74. Son CY, Kim SU, Han WK, Choi GH, Park H, Yang SC, Choi JS, Park JY, Kim do Y, Ahn SH, Chon CY, Han KH. Normal liver elasticity values using acoustic radiation force impulse imaging: a prospective study in healthy living liver and kidney donors. J Gastroenterol Hepatol. 2012;27:130-6 75. Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE, Cho JY, Yoo JE, Choi JS, Park YN. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis. Hepatology. 2011;54:1707-17. 76. Choi KK, Kim SH, Choi SB, Lim JH, Choi GH, Choi JS, Kim KS. Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26:1646-51. 77. Choi GH, Park JY, Hwang HK, Kim DH, Kang CM, Choi JS, Park YN, Kim DY, Ahn SH, Han KH, Chon CY, Lee WJ. Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma. Liver Int 2011;31:485-493. 78. Lim SO, Park YM, Kim HS, Quan X, Yoo JE, Park YN, Choi GH, Jung G. Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma. Hepatology. 2011;53:1352-62. 79. Ju MK, Choi GH, Joo DJ, Hur KH, Choi J, Kim MS, Kim SI, Kim YS. Impact of graft type on remnant liver regeneration: right hepatectomy versus extended right hepatectomy. Transplant Proc. 2010;42:4286-8. 80. Ju MK, Choi GH, Joo DJ, Hur KH, Choi J, Kim MS, Kim SI, Kim YS. Use of the hilar plate looping technique for bile duct dissection in living donor liver transplantation significantly reduces recipient biliary complications. Transplant Proc. 2010:42:4161-3. 81. Ju MK, Choi GH, Huh KH, Joo DJ, Kim SJ, Choi J, Kim MS, Kim SI, Kim YS UCSF criteria by pre-transplant radiologic study cannot assure similar post-transplant results of hepatocellular carcinoma within Milan criteria. Hepatogastroenterology. 2010;57:819-25. 82. Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. Exp Mol Pathol. 2011;90:66-73. 83. Oh BK, Um TH, Choi GH, Park YN. Frequent changes in subtelomeric DNA methylation patterns and its relevance to telomere regulation during human hepatocarcinogenesis. Int J Cancer. 2011;128:857-68. 84. Kim SU, Kim YC, Choi JS, Kim KS, Choi GH, Choi JS, Park JY, Kim do Y, Ahn SH, Choi EH, Park YN, Chon CY, Han KH, Kim MJ. Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study. Magn Reson Imaging. 2010;28:802-11. 85. Kim SU, Choi GH, Han WK, Kim BK, Park JY, Kim do Y, Choi JS, Yang SC, Choi EH, Ahn SH, Han KH, Chon CY. What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int. 2010;30:268-74. 86. Kang CM, Choi GH, Kim DH, Choi SB, Kim KS, Choi JS, Lee WJ. Revisiting the role of nonanatomic resection of small (< or = 4 cm) and single hepatocellular carcinoma in patients with well-preserved liver function. J Surg Res. 2010;160:81-9. 87. Choi GH, Han DH, Kim DH, Choi SB, Kang CM, Kim KS, Choi JS, Park YN, Park JY, Kim do Y, Han KH, Chon CY, Lee WJ. Outcome after curative resection for a huge (>or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg. 2009;198:693-701. 88. Choi GH, Kim DH, Choi SB, Kang CM, Kim KS, Choi JS, Lee WJ, Han KH, Chon CY, Kim BR. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma. J Gastroenterol Hepatol. 2009;24:391-8 89. Choi GH, Kim DH, Kang CM, Kim KS, Choi JS, Lee WJ, Kim BR. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma. Ann Surg Oncol 2008;15:618-29 90. Choi GH, Ju MK, Kim JY, Kang CM, Kim KS, Choi JS, Han KH, Park MS, Park YN, Lee WJ, Kim BR. Hepatic Splenosis Preoperatively Diagnosed as Hepatocellular Carcinoma in Patient with Chronic Hepatitis B- A Case Report. J Korean Med Sci 2008;23:336-41. 91. Choi GH, Kim DH, Kang CM, Kim KS, Choi JS, Lee WJ, Kim BR. Is Preoperative Transarterial Chemoembolization Needed for a resectable Hepatocellular Carcinoma ? World J Surg 2007;31:2370-7.